Aspirin use and the risk of prostate cancer mortality in men treated with prostatectomy or radiotherapy

Journal of Clinical Oncology

Volumn 30, Issue 28, 2012, Pages 3540-3544

  Choe, Kevin S ^a   Cowan, Janet E ^b   Chan, June M ^b   Carroll, Peter R ^b   D'Amico, Anthony V ^c   Liauw, Stanley L ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ENOXAPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BONE METASTASIS; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RISK REDUCTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASPIRIN; CHEMOPREVENTION; ENOXAPARIN; HUMANS; MALE; MIDDLE AGED; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK; TICLOPIDINE; WARFARIN;

EID: 84867055732     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.41.0308     Document Type: Article

References (35)

1. Heit JA, Silverstein MD, Mohr DN, et al: Risk factors for deep vein thrombosis and pulmonary embolism: A population-based case-control study. Arch Intern Med 160:809-815, 2000 (Pubitemid 30165241)
2. White RH, Chew HK, Zhou H, et al: Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults. Arch Intern Med 165:1782-1787, 2005 (Pubitemid 41138968)
3. Prandoni P, Lensing AW, Büller HR, et al: Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327:1128-1133, 1992
4. Sørensen HT, Mellemkjaer L, Steffensen FH, et al: The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med 338:1169-1173, 1998 (Pubitemid 28180744)
5. Bakewell SJ, Nestor P, Prasad S, et al: Platelet and osteoclast beta3 integrins are critical for bone metastasis. Proc Natl Acad Sci U S A 100:14205-14210, 2003 (Pubitemid 37499215)
6. Camerer E, Qazi AA, Duong DN, et al: Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood 104:397-401, 2004 (Pubitemid 38900020)
7. Chan TA, Morin PJ, Vogelstein B, et al: Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95:681-686, 1998 (Pubitemid 28083803)
8. Falanga A, Marchetti M, Vignoli A, et al: Clotting mechanisms and cancer: Implications in thrombus formation and tumor progression. Clin Adv Hematol Oncol 1:673-678, 2003
9. Folkman J, Langer R, Linhardt RJ, et al: Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone. Science 221:719-725, 1983 (Pubitemid 13030626)
10. Hejna M, Raderer M, Zielinski CC: Inhibition of metastases by anticoagulants. J Natl Cancer Inst 91:22-36, 1999 (Pubitemid 29042440)
11. Mahdi JG, Alkarrawi MA, Mahdi AJ, et al: Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells. Cell Prolif 39:249-260, 2006 (Pubitemid 44035900)
12. McCulloch P, George WD: Warfarin inhibition of metastasis: The role of anticoagulation. Br J Surg 74:879-883, 1987 (Pubitemid 18010978)
13. Bosetti C, Gallus S, La Vecchia C: Aspirin and cancer risk: A summary review to 2007. Recent Results Cancer Res 181:231-251, 2009
14. Maurer LH, Herndon JE 2nd, Hollis DR, et al: Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: A Cancer and Leukemia Group B study. J Clin Oncol 15:3378-3387, 1997 (Pubitemid 27485858)
15. Thun MJ, Namboodiri MM, Heath CW Jr: Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 325:1593-1596, 1991
16. Zacharski LR, Henderson WG, Rickles FR, et al: Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final report of VA Cooperative Study #75. Cancer 53:2046-2052, 1984 (Pubitemid 14101772)
17. Dasgupta K, Di Cesar D, Ghosn J, et al: Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence. Cancer J 12:130-135, 2006
18. Habel LA, Zhao W, Stanford JL: Daily aspirin use and prostate cancer risk in a large, multiracial cohort in the US. Cancer Causes Control 13:427-434, 2002 (Pubitemid 34666598)
19. Jacobs EJ, Rodriguez C, Mondul AM, et al: A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. J Natl Cancer Inst 97:975-980, 2005 (Pubitemid 41430563)
20. Mahmud SM, Franco EL, Aprikian AG: Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: A meta-analysis. Int J Cancer 127:1680-1691, 2010
21. Choe KS, Correa D, Jani AB, et al: The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy. Cancer 116:1820-1826, 2010
22. Lubeck DP, Litwin MS, Henning JM, et al: The CaPSURE database: A methodology for clinical practice and research in prostate cancer - CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 48:773-777, 1996 (Pubitemid 26398700)
23. Roach M 3rd, Hanks G, Thames H Jr, et al: Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65:965-974, 2006
24. Kawachi MH, Bahnson RR, Barry M, et al: NCCN clinical practice guidelines in oncology: Prostate cancer early detection. J Natl Compr Canc Netw 8:240-262, 2010
25. Baron JA, Cole BF, Sandler RS, et al: A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891-899, 2003 (Pubitemid 36297997)
26. Chan AT, Giovannucci EL, Meyerhardt JA, et al: Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294:914-923, 2005 (Pubitemid 41215460)
27. Sandler RS, Halabi S, Baron JA, et al: A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883-890, 2003 (Pubitemid 36297996)
28. Cuzick J, Otto F, Baron JA, et al: Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: An international consensus statement. Lancet Oncol 10:501-507, 2009
29. Jacobs EJ, Thun MJ, Bain EB, et al: A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99:608-615, 2007 (Pubitemid 47073542)
30. Hanahan D, Weinberg RA: Hallmarks of cancer: The next generation. Cell 144:646-674, 2011
31. Uluçkan O, Eagleton MC, Floyd DH, et al: APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice. J Cell Biochem 104:1311-1323, 2008 (Pubitemid 351961703)
32. Holmes MD, Chen WY, Li L, et al: Aspirin intake and survival after breast cancer. J Clin Oncol 28:1467-1472, 2010
33. Dhillon PK, Kenfield SA, Stampfer MJ, et al: Long-term aspirin use and the risk of total, high-grade, regionally advanced and lethal prostate cancer in a prospective cohort of health professionals, 1988-2006. Int J Cancer 128:2444-2452, 2011
34. Dhillon PK, Kenfield S, Stampfer MJ, et al: Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prev Res (in press)
35. Gutt R, Tonlaar N, Kunnavakkam R, et al: Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 28:2653-2659, 2010